LH
Laboratory Corp of America Holdings
Laboratory Corp of America Holdings historical holders
total: 10
Egerton Capital Laboratory Corp of America Holdings transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2018 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2018 Q3
John Armitage has been an institutional investor in Laboratory Corp of America Holdings (LH) since 2018 Q2. According to 2026 Q2 report, John Armitage doesn't hold any shares. The fund/company first acquired LH in 2018 Q2, initially purchasing 841,025 shares. Since the initial investment, Egerton Capital has made 1 more transaction in this position.
When did John Armitage exit their LH position?
John Armitage no longer holds Laboratory Corp of America Holdings (LH). They sold off their entire position in 2018 Q3, closing out an investment that began in 2018 Q2.
When did John Armitage first invest in LH?
John Armitage first invested in Laboratory Corp of America Holdings (LH) in 2018 Q2 at the reported quarter-end price of $179.53 per share, acquiring 841,025 shares in their initial purchase.
What is John Armitage's average cost basis for LH?
Based on historical transaction data, John Armitage's estimated cost basis for Laboratory Corp of America Holdings (LH) is approximately $179.53 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $179.53
- Weighted AVG sell price:
- $179.53
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.